指南与共识质量管理与危急值临床微生物分子诊断

IFCC工作组关于临床实验室预防COVID-19感染的生物安全措施建议

Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
指南 / 共识 · Clin Chem Lab Med · 2020-01-01

国际临床化学与检验医学联合会(IFCC)COVID-19工作组基于国际和国家级卫生机构官方文件,针对在生物安全水平1级(BSL-1)和2级(BSL-2)运行的常规临床化学实验室,提出了预防COVID-19感染的生物安全措施建议。文件强调新冠疫情对包括实验室专业人员在内的医护人员可能尤其危险,所提出的临时最佳实践措施有助于降低临床实验室工作期间感染COVID-19的风险。

要点

  • IFCC工作组针对BSL-1和BSL-2常规临床化学实验室提出COVID-19生物安全建议。
  • 建议改编自国际和国家级卫生机构官方文件,属临时最佳实践措施。
  • 目标为降低实验室专业人员在工作期间感染COVID-19的风险。

核心结论

  • IFCC COVID-19工作组提出的临时最佳实践措施有助于降低临床实验室工作期间感染COVID-19的风险。

研究设计与样本

  • 由国际临床化学与检验医学联合会(IFCC)COVID-19工作组制定,建议改编自国际和国家级卫生机构官方文件。
  • 适用对象为在生物安全水平1级(BSL-1)和2级(BSL-2)运行的常规临床化学实验室。

主要发现

  • COVID-19是过去20年继严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)之后第三次出现的冠状病毒暴发。
  • 许多全球卫生机构强调,此次新型冠状病毒暴发可能对包括实验室专业人员在内的医护人员尤其危险。

临床怎么用

  • 在BSL-1和BSL-2常规临床化学实验室中参照IFCC工作组建议实施生物安全措施以预防COVID-19感染。

局限性

  • 文件所提措施为临时最佳实践建议,改编自官方文件,非原始研究证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease 2019 (COVID-19) is the third coronavirus outbreak that has emerged in the past 20 years, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). One important aspect, highlighted by many global health organizations, is that this novel coronavirus outbreak may be especially hazardous to healthcare personnel, including laboratory professionals. Therefore, the aim of this document, prepared by the COVID-19 taskforce of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is to provide a set of recommendations, adapted from official documents of international and national health agencies, on biosafety measures for routine clinical chemistry laboratories that operate at biosafety levels 1 (BSL-1; work with agents posing minimal threat to laboratory workers) and 2 (BSL-2; work with agents associated with human disease which pose moderate hazard). We believe that the interim measures proposed in this document for best practice will help minimazing the risk of developing COVID-19 while working in clinical laboratories.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lippi G, Adeli K, Ferrari M, et al. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clin Chem Lab Med. 2020. PMID: 32396137. doi:10.1515/cclm-2020-0633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。